Pneumocystis jirovecii pneumonia prevention

Pneumocystis jirovecii pneumonia prevention refers to prophylactic antimicrobial therapy directed against the opportunistic fungal pathogen *Pneumocystis jirovecii* to prevent severe lower respiratory tract infection This strategy primarily targets vulnerable, immunocompromised populations, including individuals with advanced HIV infection (typically with CD4 counts below 200 cells/mm³), solid organ or hematopoietic stem cell transplant recipients, and patients receiving prolonged immunosuppress...

Pneumocystis jirovecii pneumonia prevention refers to prophylactic antimicrobial therapy directed against the opportunistic fungal pathogen *Pneumocystis jirovecii* to prevent severe lower respiratory tract infection Pathophysiologically, impaired cell-mediated immunity permits inhaled or reactivated fungal trophozoites and cysts to proliferate within the alveoli Prophylaxis aims to avert the resulting diffuse alveolar inflammation, foamy intra-alveolar exudate formation, and severe ventilation-...

This strategy primarily targets vulnerable, immunocompromised populations, including individuals with advanced HIV infection (typically with CD4 counts below 200 cells/mm³), solid organ or hematopoietic stem cell transplant recipients, and patients receiving prolonged immunosuppressive regimens or high-dose corticosteroids for malignancies and autoimmune disorders

This strategy primarily targets vulnerable, immunocompromised populations, including individuals with advanced HIV infection (typically with CD4 counts below 200 cells/mm³), solid organ or hematopoietic stem cell transplant recipients, and patients receiving prolonged immunosuppressive regimens or high-dose corticosteroids for malignancies and autoimmune disorders

Pathophysiologically, impaired cell-mediated immunity permits inhaled or reactivated fungal trophozoites and cysts to proliferate within the alveoli Prophylaxis aims to avert the resulting diffuse alveolar inflammation, foamy intra-alveolar exudate formation, and severe ventilation-perfusion mismatch that cause hypoxemic respiratory failure